Urbason solubile

How we work Tap to expand Collapse
  1. Request Message us on Telegram, WhatsApp, or Viber with the medication name, dosage, and quantity.
  2. Confirmation The operator finds the medication at the best price and tells you the final cost, including delivery.
  3. Payment We accept payment in whichever way is convenient for you.
  4. Purchase We buy the original on your behalf from a licensed pharmacy in Germany.
  5. Shipping We pack it, photograph the contents and the parcel, and send it with a tracking number. For countries outside the EU, we prepare the customs paperwork.
  6. Delivery You receive your parcel. We stay in touch for any questions.

To place an order or get a consultation
message our operator:

Urbason solubile

Strengths: 250 mg, 1000 mg
Active substance: methylprednisolone
Shelf life: long
Pack sizes: 1, 3, 5 vials per pack
Indications: systemic connective tissue diseases; acute and chronic inflammatory joint diseases, adult-onset Still’s disease, bursitis, non-specific tenosynovitis, synovitis and epicondylitis; acute rheumatism, rheumatic carditis, Sydenham’s chorea; bronchial asthma, status asthmaticus; acute and chronic allergic skin diseases, contact dermatitis, toxidermia, seborrhoeic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell’s syndrome), bullous dermatitis herpetiformis, Stevens-Johnson syndrome; cerebral oedema; allergic eye diseases and inflammatory eye diseases; primary or secondary adrenal insufficiency; congenital adrenal hyperplasia; kidney diseases of autoimmune origin; nephrotic syndrome; subacute thyroiditis; diseases of the blood and haematopoietic system; tuberculous meningitis, pulmonary tuberculosis, aspiration pneumonia; berylliosis, Loeffler’s syndrome (resistant to other therapy); lung cancer; multiple sclerosis; ulcerative colitis, Crohn’s disease, local enteritis; hepatitis; hypoglycaemic states; prevention of transplant rejection in organ transplantation; hypercalcaemia associated with oncological diseases, nausea and vomiting during cytostatic therapy; multiple myeloma